Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30

$6.83+0.08 (+1.19%)

Close on Nov 12, 2026Market cap $105.58MP/E –Yield –

Satellos Bioscience EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Satellos Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?